Article
The Tao of myeloma.
Blood - 18 Sept 2014
Boise Lawrence H, Kaufman Jonathan L, Bahlis Nizar J, Lonial Sagar, Lee Kelvin P
Abstract excerpt
Multiple myeloma is a plasma cell malignancy in which significant advances have been observed during the last 15 years. Our understanding of the disease has been advanced through its molecular characterization. We have also seen improvements in patient care with the development of 2 new classes of active agents, proteasome inhibitors and immunomodulatory drugs (IMiDs), resulting in a significant improvement in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
